Medtech Insight RSS Feed - Infectious Diseases

Menopause, Heart Disease, Alzheimer’s Are All Part Of Women’s Health, Industry Leaders Say

Marion Webb — Tue, 31 Mar 2026 23:19:58 +0000

Women’s health investment is increasingly framed as one of the largest untapped opportunities and is expected to reach more than $600bn by 2030, according to PwC. Yet the lion’s share of funding conti

Former CMS Top Official Says Brain-Computer Interface Development Outpaces CMS Coverage

Marion Webb — Mon, 30 Mar 2026 17:49:56 +0000

Implantable brain-computer interfaces (iBCI) hold tremendous potential to help people with severe neurological disabilities communicate with the outside world. But experts warn that without a clear Me

Medtronic Takes On Boston Scientific In Back Pain With ViaVerte BVNA Deal

Shubham Singh — Thu, 26 Mar 2026 15:20:00 +0000

Medtronic has added basivertebral nerve ablation to its pain treatment portfolio through a distribution agreement with Merit Medical, under which the company will commercialize the ViaVerte system for

Cognito Shows Off More Positive Data For Device-Based Alzheimer’s Treatment

George Underwood — Thu, 19 Mar 2026 13:00:00 +0000

Cognito Therapeutics, fresh off a $105m funding round, has announced new positive data for Spectris, its at-home, device-based therapy for Alzheimer’s disease. The Spectris headset delivers calibrated

BCI Maker Paradromics Builds Academic Network To Advance Brain-Computer Interface Research

Marion Webb — Tue, 17 Mar 2026 13:00:00 +0000

As brain-computer interface company Paradromics is recruiting a patient for the first-in-human trial of its Connexus BCI aimed at restoring speech, its chief scientific officer is already planning for

Cognito Raises $105M Series C Round To Fund Alzheimer’s Device, Adds Brain Health Partners

Marion Webb — Thu, 05 Mar 2026 13:05:52 +0000

Cognito Therapeutics reached another milestone on its path to advancing its at-home, device-based therapy for Alzheimer’s disease as the company moves toward pivotal trial results and a planned US lau

Reimbursement Still Missing Piece As Neuroscience Speeds Ahead

David Wild — Tue, 24 Feb 2026 19:22:13 +0000

Christian Howell has heard the good news and the bad news about US Food and Drug Administration breakthrough designation. The good news is that Cognito Therapeutics, which he heads, earned it back in

J&J Unit Cerenovus Recalls Aneurysm Treatment Systems Following Patient Death

Elizabeth Orr — Thu, 05 Feb 2026 22:11:52 +0000

A line of aneurysm treatment tools from Johnson & Johnson MedTech business unit Cerenovus has been taken off the market after repeated product failures linked to four serious injuries and one deat

BCI Developer INBRAIN Races Ahead With Bidirectional Chip, Merck Commercialization Letter, Trial

Marion Webb — Tue, 03 Feb 2026 18:16:19 +0000

During its five-year anniversary event in Barcelona, INBRAIN Neuroelectronics unveiled several new developments aimed at positioning the company’s novel graphene-based technology as a leading platform

At INBRAIN’s 5-Year Mark, BCI Experts Confront The Promise, Perils Of Brain-Computer Interfaces

Marion Webb — Mon, 02 Feb 2026 16:17:54 +0000

The choice of Barcelona’s historic La Llotja de Mar as the venue to celebrate the five-year anniversary of INBRAIN Neuroelectronics, the Spanish developer of graphene-based brain-computer interface, w

When Brain-Computer Interfaces Fail, Human Trial Participants Have Few Options

Marion Webb — Thu, 29 Jan 2026 15:37:14 +0000

Brain-computer interfaces (BCIs) that can help people with severe neurological conditions move their limbs again, communicate with digital devices, even restore speech, are considered on the verge of

Former Zynex Execs Indicted In $873M Fraud Case

Elizabeth Orr — Tue, 27 Jan 2026 03:19:25 +0000

Two former Zynex Inc. executives are facing federal fraud and conspiracy charges for allegedly collecting more than $873m on unnecessary pain management devices and supplies. A Rhode Island federal ju

Naox’s 2026 Vision: FDA-Cleared In-Ear EEG Targets Epilepsy And Brain Health For Consumers

Marion Webb — Thu, 15 Jan 2026 20:48:20 +0000

French start-up Naox Technologies kicked off the CES conference with a US regulatory nod for its Link in-ear electroencephalography (EEG) system and used the big tech extravaganza to showcase a protot

Blood, Games, BrainMRI – NeuroAge Gives You Tools To Reprogram Brain Age, Reduce Alzheimer’s Risk

Marion Webb — Wed, 14 Jan 2026 20:10:52 +0000

Motivated by her own family history of Alzheimer’s disease, NeuroAge Therapeutics’ co-founder Christin Glorioso is on a mission to reverse brain aging and mitigate the risk of age-related brain diseas

Robot Dogs, Smart Glasses, Digital Companions And Sleep Headbands: AgeTech Shines At CES

Marion Webb — Mon, 12 Jan 2026 23:08:09 +0000

At this year’s CES, technologies that can help aging people enhance their quality of life, age healthier, and support independent living had a notable presence. Innovations that integrate technology w

Neuroethicists Advocate For More Guidelines For Neurotech

Marion Webb — Fri, 19 Dec 2025 00:36:10 +0000

As brain-computer interface companies (BCI) develop devices to help people with neurological conditions such as epilepsy, spinal cord injuries, ALS and stroke communicate by converting signals from th

Neurotechnology Progress Fuels Urgency Of Neural Data Privacy Regulation

Marion Webb — Mon, 15 Dec 2025 20:54:03 +0000

As neurotechnology companies race to release devices, concerns are mounting over how users’ sensitive neural data is being collected, used or sold. Four US states – Colorado, California, Connecticut a

Subsense Raises $10M To Advance Nanoparticle-Based Brain-Computer Interface Approach

Marion Webb — Thu, 11 Dec 2025 23:36:40 +0000

Palo Alto-based neurotech start-up Subsense hit another milestone by raising $10m in additional seed funding, bringing its total funding to $27m. Following an initial $17m in seed funding in May, Subs

Flow Wins FDA Approval For Depression Treatment Device

Elizabeth Orr — Thu, 11 Dec 2025 23:15:18 +0000

Flow Neuroscience won US Food and Drug Administration approval for its at-home brain stimulation device for treating depression on Dec. 11, ending regulatory delays that had frustrated the company. In

Paradromics Joins Neurotech Race With FDA Nod To Test BCI For Restoring Speech

Marion Webb — Tue, 02 Dec 2025 23:29:14 +0000

Paradromics announced it has received US Food and Drug Administration approval to assess the safety and capabilities of its brain-computer interface (BCI) to restore speech in two patients with impair